References
- Byrne R, Sinha S, Chaudhuri KR. Restless legs syndrome: diagnosis and review of management options. Neuropsychiatr Dis Treat. 2006;2(2):155–164.
- Willis T. The London practice book of physick. London: Bassett & Crook; 1685.
- Zucconi M, Galbiati A, Rinaldi F, et al. An update on the treatment of Restless Legs Syndrome/Willis-Ekbom Disease: prospects and challenges. Expert Rev Neurother. 2018;18:705–713.
- Leschziner G, Gringras P. Restless legs syndrome. BMJ. 2012;344:e3056.
- Hogl B, Kiechl S, Willeit J, et al. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology. 2005;64(11):1920–1924.
- Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010;6(6):337–346.
- Ohayon MM, O’Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012;16(4):283–295.
- Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med. 2014;15(8):860–873.
- Trenkwalder C, Hening WA, Walters AS, et al. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord. 1999;14(1):102–110.
- Hening WA, Walters AS, Wagner M, et al. Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep. 1999;22(7):901–912.
- Ekbom A. Restless legs. Acta Med Scand. 1945;158:1–123.
- Hening WA. Restless legs syndrome: the most common and least diagnosed sleep disorder. Sleep Med. 2004;5(5):429–430.
- Holmes R, Tluk S, Metta V. et al. Nature and variants of idiopathic restless legs syndrome: observations from 152 patients referred to secondary care in the UK. J Neural Transm. 2007;114(7):929–934.
- Homyak M, Feige B, Voderholzer U, et al. Polysomnography findings in patients with restless legs syndrome and in healthy controls: a comparative observational study. Sleep. 2007;30(7):861–865.
- Winkelmann J, Prager M, Lieb R, et al. “Anxietas tibiarum”. Depression and anxiety disorders in patients with restless legs syndrome. J Neurol. 2005;252(1):67–71.
- Happe S, Reese JP, Stiasny-Kolster K, et al. Assessing health-related quality of life in patients with restless legs syndrome. Sleep Med. 2009;10(3):295–305.
- Hogl B, Gschliesser V. RLS assessment and sleep questionnaires in practice–lessons learned from Parkinson’s disease. Sleep Med. 2007;8:S7–12.
- Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006;21(7):916–923.
- Tomlinson CL, Stowe R, Patel S, et al. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2010;25(15):2649–2653.
- Chaudhuri KR, Sauerbier A, Rojo JM, et al. The burden of non-motor symptoms in Parkinson’s disease using a self-completed non-motor questionnaire: a simple grading system. Parkinsonism Relat Disord. 2015;21(3):287–291.
- Allen RP, Kushida CA, Atkinson MJ. Factor analysis of the International Restless Legs Syndrome Study Group’s scale for restless legs severity. Sleep Med. 2003;4(2):133–135.
- Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121–132.
- Martinez-Martin P, Schapira AH, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord. 2007;22(11):1623–1629.
- Sevim S, Dogu O, Kaleagasi H, et al. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry. 2004;75(2):226–230.
- Cho SJ, Hong JP, Hahm BJ, et al. Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep. 2009;32(8):1069–1076.
- Scholz H, Benes H, Happe S, et al. Psychological distress of patients suffering from restless legs syndrome: a cross-sectional study. Health Qual Life Outcomes. 2011;9:73.
- Li Y, Mirzaei F, O’Reilly EJ, et al. Prospective study of restless legs syndrome and risk of depression in women. Am J Epidemiol. 2012;176(4):279–288.
- Trautmann E, Barke A, Frisch JU, et al. Restless legs syndrome: psychiatric comorbidities are more important than neuroticism. Behav Sleep Med. 2015;13(5):375–386.
- Tikkinen KA, Auvinen A, Johnson TM 2nd, et al. A systematic evaluation of factors associated with nocturia–the population-based FINNO study. Am J Epidemiol. 2009;170(3):361–368.
- Yoshimura K, Oka Y, Kamoto T, et al. Differences and associations between nocturnal voiding/nocturia and sleep disorders. BJU Int. 2010;106(2):232–237.
- Fulda S, Beitinger ME, Reppermund S, et al. Short-term attention and verbal fluency is decreased in restless legs syndrome patients. Mov Disord. 2010;25(15):2641–2648.
- Sanghera MK, Sales SG, Robinson JL, et al. Restless legs syndrome: associated non-motor symptoms and medical comorbidities: a controlled study. J Parkinsonism Restless Legs Syndrome. 2015;5:33–38.
- Gunther R, Richter N, Sauerbier A, et al. Non-motor symptoms in patients suffering from motor neuron diseases. Front Neurol. 2016;7:117.
- Martinez-Martin P. Nonmotor symptoms and health-related quality of life in early Parkinson’s disease. Mov Disord. 2014;29(2):166–168.
- Rinaldi F, Galbiati A, Marelli S, et al. Defining the phenotype of restless legs syndrome/Willis-Ekbom disease (RLS/WED): a clinical and polysomnographic study. J Neurol. 2016;263(2):396–402.
- Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med. 1991;229(2):131–134.
- Chaudhuri KR, Odin P, Antonini A, et al. Parkinson&2019;s disease: the non-motor issues. Parkinsonism Relat Disord. 2011;17(10):717–723.
- Wittmaak T. Pathologie und Therapie des Sensibilitӓts-Neurosen. Lehrbuch der Nervenkarankheitenm Teil 1: Pathologie und Therapie der sensiblen Neurosen. Leipzig: E.Schӓfer; 1861.
- Lee HB, Hening WA, Allen RP, et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci. 2008;20(1):101–105.
- Merlino G, Valente M, Serafini A, et al. Effects of restless legs syndrome on quality of life and psychological status in patients with type 2 diabetes. Diabetes Educ. 2010;36(1):79–87.
- Szentkiralyi A, Volzke H, Hoffmann W, et al. The relationship between depressive symptoms and restless legs syndrome in two prospective cohort studies. Psychosom Med. 2013;75(4):359–365.42.
- Hornyak M, Trenkwalder C, Kohnen R, et al. Efficacy and safety of dopamine agonists in restless legs syndrome. Sleep Med. 2012;13(3):228–236.
- Mol M, Carpay M, Ramakers I, et al. The effect of perceived forgetfulness on quality of life in older adults; a qualitative review. Int J Geriatr Psychiatry. 2007;22(5):393–400.
- Kerr S, McKinon W, Bentley A. Descriptors of restless legs syndrome sensations. Sleep Med. 2012;13(4):409–413.
- Karroum EG, Golmard JL, Leu-Semenescu S, et al. Painful restless legs syndrome: a severe, burning form of the disease. Clin J Pain. 2015;31(5):459–466.
- Cho YW, Song ML, Earley CJ, et al. Prevalence and clinical characteristics of patients with restless legs syndrome with painful symptoms. Sleep Med. 2015;16(6):775–778.
- Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5(3):237–246.
- Trenkwalder C, Zieglgansberger W, Ahmedzai SH, et al. Pain, opioids, and sleep: implications for restless legs syndrome treatment. Sleep Med. 2017;31:78–85.
- Trenkwalder C, Benes H, Grote L, et al. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 2013;12(12):1141–1150.
- Kallweit U, Siccoli MM, Poryazova R, et al. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment. Eur Neurol. 2009;62(3):176–179.
- Song P, Park HS, Joo EY. et al. How do restless legs syndrome patients recognize daytime sleepiness? - The multiple sleep latency test. Sleep Med Res. 2011;2(3):102–106.
- Iranzo A. Parasomnias and sleep-related movement disorders in older adults. Sleep Med Clin. 2018;13(1):51–61.
- Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010;25(6):704–709.